Ads
related to: hepatitis c drug treatment pricing
Search results
Results from the WOW.Com Content Network
Hepatitis C Drugs Can Cost $84,000. This New One May Be Just As Good—But Cost $300
A 2020 study comparing United States and Canadian hepatitis C medication prices looked at the estimated costs of a 28-day supply of certain drugs in 2019. The drug prices were as follows: The drug ...
According to the California Technology Assessment Forum, a panel of academic pharmacoeconomic experts, representatives of managed care organizations, and advocates for people with hepatitis, a 46% discount would bring the average price of treatment to about $40,000, at which price sofosbuvir-based treatment regimens represent a "high value" for ...
By 2014 the price of Gilead's specialty drug for hepatitis C, Sovaldi or sofosbuvir, was $84,000 to $168,000 for a course of treatment in the U.S., £35,000 in the UK for 12 weeks. [92] Sovaldi is on the World Health Organization's most important medications needed in a basic health system and the steep price is highly controversial.
The cost of telaprevir-based triple therapy for hepatitis C is $189,000 per sustained viral response. [11] On August 12, 2014, Vertex Pharmaceuticals announced that it would discontinue production of its brand of telaprevir, Incivek, due to falling demand for the drug caused by competition from newer hepatitis C treatments. [12]
AARP said average list prices on 25 drugs collectively cost Medicare nearly $50 billion in 2022. ... the list price of hepatitis C drug Epclusa hasn't increased since it was approved in 2016.
Ads
related to: hepatitis c drug treatment pricing